Disclosures for "ME&MG, Novel Digital Device for Patients with Generalized Myasthenia Gravis: A First Step Towards Validation"
-
Dr. Berling has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Adscientiam. Dr. Berling has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche.
-
-
Prof. NICOLAS has nothing to disclose.
-
The institution of Prof. Prigent has received research support from VLM - Patients association for lysosomial diseases. The institution of Prof. Prigent has received research support from ADEP Assitance.
-
Ghislain N'Dah-Sekou has nothing to disclose.
-
Dr. Carment has received personal compensation for serving as an employee of Ad Scientiam.
-
Dr. Gorin has received personal compensation for serving as an employee of Ad Scientiam.
-
Miss Klaeylé has received personal compensation for serving as an employee of Ad Scientiam.
-
Miss Ravindra has received personal compensation for serving as an employee of Ad Scientiam.
-
Mrs. Touré Cuq has received personal compensation for serving as an employee of Ad Scientiam .
-
Dr. Vives has received personal compensation for serving as an employee of Ad Scientiam.
-
Dr. Keller has received personal compensation for serving as an employee of Alexion. Dr. Keller has stock in Alexion, Roche, Novartis, Celgene, Abbvie, Merck, Ionis, Sanofie, Organon, MSD.
-
Dr. Aras has received personal compensation for serving as an employee of Alexion Pharmaceuticals Inc.
-
Saad Zinai has received personal compensation for serving as an employee of Ad Scientiam.
-
Pascal Lafort has received personal compensation in the range of $500-$4,999 for serving as a Consultant for sanofi . An immediate family member of Pascal Lafort has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. Pascal Lafort has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Pascal Lafort has received personal compensation in the range of $0-$499 for serving as a Consultant for Amicus. Pascal Lafort has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Pascal Lafort has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for genzyme sanofi. Pascal Lafort has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sparks therapeutics. Pascal Lafort has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Pascal Lafort has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus therapeutics. Pascal Lafort has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Pascal Lafort has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme Sanofi. Pascal Lafort has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Revue Neurologique. The institution of Pascal Lafort has received research support from Genzyme Sanofi. The institution of Pascal Lafort has received research support from Genzyme sanofi. The institution of Pascal Lafort has received research support from Amicus therapeutics. The institution of Pascal Lafort has received research support from AMICUS Therapeutics.